Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features

Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
BMC Cancer (Impact Factor: 3.32). 05/2010; 10:227. DOI: 10.1186/1471-2407-10-227
Source: PubMed

ABSTRACT Most previous studies of the CpG island methylator phenotype (CIMP) in colorectal cancer (CRC) have been conducted on a relatively small numbers of CpG sites. In the present study we performed comprehensive DNA methylation profiling of CRC with the aim of characterizing CIMP subgroups.
DNA methylation at 1,505 CpG sites in 807 cancer-related genes was evaluated using the Illumina GoldenGate methylation array in 28 normal colonic mucosa and 91 consecutive CRC samples. Methylation data was analyzed using unsupervised hierarchical clustering. CIMP subgroups were compared for various clinicopathological and molecular features including patient age, tumor site, microsatellite instability (MSI), methylation at a consensus panel of CpG islands and mutations in BRAF and KRAS.
A total of 202 CpG sites were differentially methylated between tumor and normal tissue. Unsupervised hierarchical clustering of methylation data from these sites revealed the existence of three CRC subgroups referred to as CIMP-low (CIMP-L, 21% of cases), CIMP-mid (CIMP-M, 14%) and CIMP-high (CIMP-H, 65%). In comparison to CIMP-L tumors, CIMP-H tumors were more often located in the proximal colon and showed more frequent mutation of KRAS and BRAF (P<0.001).
Comprehensive DNA methylation profiling identified three CRC subgroups with distinctive clinicopathological and molecular features. This study suggests that both KRAS and BRAF mutations are involved with the CIMP-H pathway of CRC rather than with distinct CIMP subgroups.

Download full-text


Available from: Barry Iacopetta, Aug 04, 2015
  • Source
    • "We therefore used this delta b-value to determine significant differences in methylation. It is worth noting that this value is among the more stringent values used in previous studies (Martin-Subero et al, 2009; Richter et al, 2009; Ang et al, 2010). Of the genes included on the GoldenGate array, 131 (16%) were significantly more methylated in YSTs than in germinomas (Supplementary Table 1; X-chromosome genes were excluded as they would normally differ between male and female subjects due to X-chromosome inactivation.). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Yolk sac tumours (YSTs) and germinomas are the two major pure histological subtypes of germ cell tumours. To date, the role of DNA methylation in the aetiology of this class of tumour has only been analysed in adult testicular forms and with respect to only a few genes. A bank of paediatric tumours was analysed for global methylation of LINE-1 repeat elements and global methylation of regulatory elements using GoldenGate methylation arrays. Both germinomas and YSTs exhibited significant global hypomethylation of LINE-1 elements. However, in germinomas, methylation of gene regulatory regions differed little from control samples, whereas YSTs exhibited increased methylation at a large proportion of the loci tested, showing a 'methylator' phenotype, including silencing of genes associated with Caspase-8-dependent apoptosis. Furthermore, we found that the methylator phenotype of YSTs was coincident with higher levels of expression of the DNA methyltransferase, DNA (cytosine-5)-methyltransferase 3B, suggesting a mechanism underlying the phenotype. Epigenetic silencing of a large number of potential tumour suppressor genes in YSTs might explain why they exhibit a more aggressive natural history than germinomas and silencing of genes associated with Caspase-8-dependent cell death might explain the relative resistance of YSTs to conventional therapy.
    British Journal of Cancer 06/2011; 105(4):575-85. DOI:10.1038/bjc.2011.218 · 4.82 Impact Factor
  • Source
    • "Such molecular pathology has contributed to the discovery of subtypes of several different tumor types and has successfully identified patients with different survival times (Beer et al., 2002; van de Vijver et al., 2002; van't Veer et al., 2002). More recently, there has been substantial interest in the use of methylation profiling for understanding the effect of epigenetic alterations on disease susceptibility as well as to characterize cancer subtypes based on methylation patterns (Ang et al., 2010; Christensen et al., 2009b, c; Deneberg et al., 2010; Marsit et al., 2009). However, such associations work best when cancer subtypes based on genetic profiles are already known. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Patients with identical cancer diagnoses often progress differently. The disparity we see in disease progression and treatment response can be attributed to the idea that two histologically similar cancers may be completely different diseases on the molecular level. Methods for identifying cancer subtypes associated with patient survival have the capacity to be powerful instruments for understanding the biochemical processes that underlie disease progression as well as providing an initial step toward more personalized therapy for cancer patients. We propose a method called semi-supervised recursively partitioned mixture models (SS-RPMM) that utilizes array-based genetic and patient-level clinical data for finding cancer subtypes that are associated with patient survival. In the proposed SS-RPMM, cancer subtypes are identified using a selected subset of genes that are associated with survival time. Since survival information is used in the gene selection step, this method is semi-supervised. Unlike other semi-supervised clustering classification methods, SS-RPMM does not require specification of the number of cancer subtypes, which is often unknown. In a simulation study, our proposed method compared favorably with other competing semi-supervised methods, including: semi-supervised clustering and supervised principal components analysis. Furthermore, an analysis of mesothelioma cancer data using SS-RPMM, revealed at least two distinct methylation profiles that are informative for survival. The analyses implemented in this article were carried out using R (; Supplementary data are available at Bioinformatics online.
    Bioinformatics 10/2010; 26(20):2578-85. DOI:10.1093/bioinformatics/btq470 · 4.62 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This copy of the thesis has been supplied on condition that anyone who consults it is understood to recognise that its copyright rests with the author and that no quotation from the thesis, nor any information derived therefrom, may be published without the author's prior, written consent.
Show more